SC
Simon, Christopher
董事长兼首席执行官
C-suiteM
内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Simon, Christopher, 董事长兼首席执行官. Director active across 3 companies, notably HAEMONETICS CORP. Aggregated, 22 reports have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €479k. History available since 17 May 2021. The latest transaction was disclosed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Simon, Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
66,666 股0Common StockSEC:0001127602-25-016532:0
19,132 股0Common Stock, $0.01 par value per share ("Common Stock")SEC:0000950170-25-077776:0
21,405 股Common StockSEC:0001127602-25-015052:0
2,391 股@ US$69.381.1% 占其流量Common StockSEC:0001127602-25-014933:0
39,704 股@ US$75.5620.3% 占其流量Common StockSEC:0001127602-24-023305:0
104,516 股@ US$41.6429.9% 占其流量Common StockSEC:0001127602-24-018160:0
106,062 股0Common StockSEC:0001127602-24-016803:0
4,037 股@ US$95.732.7% 占其流量Common StockSEC:0001127602-24-016160:0
1,480 股@ US$96.491.0% 占其流量Common StockSEC:0001127602-24-015854:0
38,900 股0Common StockSEC:0001127602-24-009995:0
196,746 股@ US$28.61538.8% 占其流量Common StockSEC:0001127602-23-019619:0
3,839 股@ US$83.342.2% 占其流量Common StockSEC:0001127602-23-016309:0
18,225 股Common StockSEC:0001127602-23-015925:0
854 股@ US$88.160.5% 占其流量Common StockSEC:0001127602-23-015735:0
8,600 股0Common StockSEC:0001127602-22-025631:0
1,148 股@ US$62.600.0026% mcap14.4% 占其流量Common StockSEC:0001127602-22-017539:0
2,496 股@ US$59.100.0053% mcap29.1% 占其流量Common StockSEC:0001127602-22-015375:0
832 股@ US$56.100.0017% mcap9.3% 占其流量Common StockSEC:0001127602-22-014951:0
1,200 股@ US$59.870.4% 占其流量Common StockSEC:0001127602-21-020048:0
2,715 股@ US$55.090.9% 占其流量Common StockSEC:0001127602-21-019521:0
26,515 股Common StockSEC:0001127602-21-017675:0
956 股@ US$55.970.3% 占其流量Common StockSEC:0001127602-21-017256:0
About Simon, Christopher
Christopher Simon is President-CEO. He has 22 filings in total, and across the 22 tracked filings, sales amount to EUR 479095 and purchases to EUR 0, with activity observed from 2021-05-18 to 2025-06-03. The recent filings mainly concern HAEMONETICS CORP, and the largest reported amounts are EUR 5180227.695450745 on 2023-06-30, EUR 3994743.56523336 on 2024-06-07, and EUR 2707501.047173842 on 2024-09-03.